According to the two companies, their corona vaccine prevents 95 percent of Covid-19 diseases. BioNTech and Pfizer plan to produce up to 50 million doses of vaccine in the remainder of 2020 and up to 1.3 billion next year.
The UK government has recently announced the emergency-use authorization of the BioNTech Covid-19 vaccine, making it the first vaccine to be approved in a Western nation.
To manage its processes, BioNTech relies on ADONIS, the BPM (Business Process Management) suite of the BOC Group.
ADONIS is the intuitive and powerful, fully web-based BPM tool for all parties involved in process management, from the joint modelling of smart processes to the comprehensive analysis, optimization and execution of processes.
BOC Group develops software products and services for effective and extensive Business Management in an era of digital transformation. The main strengths lie in improving Enterprise Architecture and Business Process Management capabilities as well as facilitating better Governance, Risk and Compliance to assure audit-readiness.